Have a feature idea you'd love to see implemented?
Let us know!
THRD Third Harmonic Bio Inc
Price (delayed)
$10.84
Market cap
$488.43M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.96
Enterprise value
$195.29M
Highlights
Third Harmonic Bio's debt has decreased by 17% YoY and by 5% QoQ
The equity rose by 15% QoQ and by 8% YoY
THRD's quick ratio is down by 10% year-on-year but it is up by 4.2% since the previous quarter
The company's net income fell by 20% QoQ and by 10% YoY
The company's EPS fell by 17% QoQ
Key stats
What are the main financial stats of THRD
Market
Valuations
Earnings
Shares outstanding
45.06M
Market cap
$488.43M
Enterprise value
$195.29M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$39.2M
EBIT
-$39.2M
EBITDA
-$38.44M
Free cash flow
-$28.88M
Per share
Balance sheet
Liquidity
EPS
-$0.96
EPS diluted
-$0.96
Free cash flow per share
-$0.7
Book value per share
$7.17
Revenue per share
$0
TBVPS
$7.37
Total assets
$304.49M
Total liabilities
$9.64M
Debt
$3.4M
Equity
$294.85M
Working capital
$293.17M
Debt to equity
0.01
Current ratio
42.5
Quick ratio
41.97
Net debt/EBITDA
7.63
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-14%
Return on equity
-14.5%
Return on invested capital
-619.2%
Return on capital employed
-13.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
THRD stock price
How has the Third Harmonic Bio stock price performed over time
Intraday
-0.37%
1 week
-3.73%
1 month
-6.71%
1 year
1.69%
YTD
-1.19%
QTD
-20%
Financial performance
How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$52.84M
Net income
-$39.2M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 20% QoQ and by 10% YoY
THRD's operating income is down by 13% since the previous quarter and by 12% year-on-year
Growth
What is Third Harmonic Bio's growth rate over time
Valuation
What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
1.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 17% QoQ
The stock's price to book (P/B) is 16% less than its last 4 quarters average of 1.8
The equity rose by 15% QoQ and by 8% YoY
Efficiency
How efficient is Third Harmonic Bio business performance
THRD's ROIC is down by 30% YoY and by 29% from the previous quarter
The return on equity has declined by 18% since the previous quarter and by 15% year-on-year
THRD's return on assets is down by 18% since the previous quarter and by 14% year-on-year
Dividends
What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for THRD.
Financial health
How did Third Harmonic Bio financials performed over time
Third Harmonic Bio's total assets has increased by 15% from the previous quarter and by 8% YoY
THRD's quick ratio is down by 10% year-on-year but it is up by 4.2% since the previous quarter
Third Harmonic Bio's debt is 99% lower than its equity
The company's debt to equity has shrunk by 50% YoY
Third Harmonic Bio's debt has decreased by 17% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.